304 related articles for article (PubMed ID: 25024217)
21. A20 expression in dendritic cells protects mice from LPS-induced mortality.
Xuan NT; Wang X; Nishanth G; Waisman A; Borucki K; Isermann B; Naumann M; Deckert M; Schlüter D
Eur J Immunol; 2015 Mar; 45(3):818-28. PubMed ID: 25472594
[TBL] [Abstract][Full Text] [Related]
22. The ubiquitin-editing enzyme A20 (TNFAIP3) is a central regulator of immunopathology.
Vereecke L; Beyaert R; van Loo G
Trends Immunol; 2009 Aug; 30(8):383-91. PubMed ID: 19643665
[TBL] [Abstract][Full Text] [Related]
23. Aggravation of post-ischemic liver injury by overexpression of A20, an NF-κB suppressor.
Yu J; Lee HS; Lee SM; Yu HC; Moon WS; Chung MJ; Park JW; Park BH
J Hepatol; 2011 Aug; 55(2):328-36. PubMed ID: 21167234
[TBL] [Abstract][Full Text] [Related]
24. A20 regulates atherogenic interferon (IFN)-γ signaling in vascular cells by modulating basal IFNβ levels.
Moll HP; Lee A; Minussi DC; da Silva CG; Csizmadia E; Bhasin M; Ferran C
J Biol Chem; 2014 Nov; 289(45):30912-24. PubMed ID: 25217635
[TBL] [Abstract][Full Text] [Related]
25. Context-dependent cooperation between nuclear factor κB (NF-κB) and the glucocorticoid receptor at a TNFAIP3 intronic enhancer: a mechanism to maintain negative feedback control of inflammation.
Altonsy MO; Sasse SK; Phang TL; Gerber AN
J Biol Chem; 2014 Mar; 289(12):8231-9. PubMed ID: 24500711
[TBL] [Abstract][Full Text] [Related]
26. A20 suppresses vascular inflammation by recruiting proinflammatory signaling molecules to intracellular aggresomes.
Enesa K; Moll HP; Luong L; Ferran C; Evans PC
FASEB J; 2015 May; 29(5):1869-78. PubMed ID: 25667218
[TBL] [Abstract][Full Text] [Related]
27. Adeno-associated virus serotype 8 (AAV8) delivery of recombinant A20 to skeletal muscle reduces pathological activation of nuclear factor (NF)-κB in muscle of mdx mice.
Charan RA; Niizawa G; Nakai H; Clemens PR
Mol Med; 2013 Feb; 18(1):1527-35. PubMed ID: 23154638
[TBL] [Abstract][Full Text] [Related]
28. Interleukin-17 (IL-17)-induced microRNA 873 (miR-873) contributes to the pathogenesis of experimental autoimmune encephalomyelitis by targeting A20 ubiquitin-editing enzyme.
Liu X; He F; Pang R; Zhao D; Qiu W; Shan K; Zhang J; Lu Y; Li Y; Wang Y
J Biol Chem; 2014 Oct; 289(42):28971-86. PubMed ID: 25183005
[TBL] [Abstract][Full Text] [Related]
29. A20 Curtails Primary but Augments Secondary CD8
Just S; Nishanth G; Buchbinder JH; Wang X; Naumann M; Lavrik I; Schlüter D
Sci Rep; 2016 Dec; 6():39796. PubMed ID: 28004776
[TBL] [Abstract][Full Text] [Related]
30. Unleashing antitumor T-cell activation without ensuing autoimmunity: the case for A20-deletion in adoptive CD8
Verdeil G; Schmitt-Verhulst AM
Oncoimmunology; 2014 Oct; 3(10):e958951. PubMed ID: 25941582
[TBL] [Abstract][Full Text] [Related]
31. A20 Restrains Thymic Regulatory T Cell Development.
Fischer JC; Otten V; Kober M; Drees C; Rosenbaum M; Schmickl M; Heidegger S; Beyaert R; van Loo G; Li XC; Peschel C; Schmidt-Supprian M; Haas T; Spoerl S; Poeck H
J Immunol; 2017 Oct; 199(7):2356-2365. PubMed ID: 28842469
[TBL] [Abstract][Full Text] [Related]
32. Homeostatic MyD88-dependent signals cause lethal inflamMation in the absence of A20.
Turer EE; Tavares RM; Mortier E; Hitotsumatsu O; Advincula R; Lee B; Shifrin N; Malynn BA; Ma A
J Exp Med; 2008 Feb; 205(2):451-64. PubMed ID: 18268035
[TBL] [Abstract][Full Text] [Related]
33. The deubiquitinase activity of A20 is dispensable for NF-κB signaling.
De A; Dainichi T; Rathinam CV; Ghosh S
EMBO Rep; 2014 Jul; 15(7):775-83. PubMed ID: 24878851
[TBL] [Abstract][Full Text] [Related]
34. Ubiquitin-editing enzyme A20 promotes tolerance to lipopolysaccharide in enterocytes.
Wang J; Ouyang Y; Guner Y; Ford HR; Grishin AV
J Immunol; 2009 Jul; 183(2):1384-92. PubMed ID: 19570823
[TBL] [Abstract][Full Text] [Related]
35. Tnfaip3 expression in pulmonary conventional type 1 Langerin-expressing dendritic cells regulates T helper 2-mediated airway inflammation in mice.
Vroman H; van Uden D; Bergen IM; van Hulst JAC; Lukkes M; van Loo G; Clausen BE; Boon L; Lambrecht BN; Hammad H; Hendriks RW; Kool M
Allergy; 2020 Oct; 75(10):2587-2598. PubMed ID: 32329078
[TBL] [Abstract][Full Text] [Related]
36. In Vivo Silencing of A20 via TLR9-Mediated Targeted SiRNA Delivery Potentiates Antitumor Immune Response.
Braun FC; van den Brandt J; Thomas S; Lange S; Schrank J; Gand C; Przybylski GK; Schmoeckel K; Bröker BM; Schmidt CA; Grabarczyk P
PLoS One; 2015; 10(9):e0135444. PubMed ID: 26327508
[TBL] [Abstract][Full Text] [Related]
37. Alternative expression pattern of MALT1-A20-NF-κB in patients with rheumatoid arthritis.
Wang X; Zhu L; Liao Z; Zhang F; Xu L; Xu Y; Chen S; Yang L; Zhou Y; Li Y
J Immunol Res; 2014; 2014():492872. PubMed ID: 24971370
[TBL] [Abstract][Full Text] [Related]
38. Nuclear factor-kappaB regulates beta-cell death: a critical role for A20 in beta-cell protection.
Liuwantara D; Elliot M; Smith MW; Yam AO; Walters SN; Marino E; McShea A; Grey ST
Diabetes; 2006 Sep; 55(9):2491-501. PubMed ID: 16936197
[TBL] [Abstract][Full Text] [Related]
39. The A20 gene protects kidneys from ischaemia/reperfusion injury by suppressing pro-inflammatory activation.
Lutz J; Luong le A; Strobl M; Deng M; Huang H; Anton M; Zakkar M; Enesa K; Chaudhury H; Haskard DO; Baumann M; Boyle J; Harten S; Maxwell PH; Pusey C; Heemann U; Evans PC
J Mol Med (Berl); 2008 Dec; 86(12):1329-39. PubMed ID: 18813897
[TBL] [Abstract][Full Text] [Related]
40. A20 inhibits human salivary adenoid cystic carcinoma cells invasion via blocking nuclear factor-kappaB activation.
Zhang B; Guan CC; Chen WT; Zhang P; Yan M; Shi JH; Qin CL; Yang Q
Chin Med J (Engl); 2007 Oct; 120(20):1830-5. PubMed ID: 18028781
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
